SCHEMBL8625942

SCHEMBL8625942

CC(C)(C)CC(=O)OC1CC(c2ccc(NC(=O)OC(C)(C)C)cc2)=NO1

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP17A1 P05093 3/20 0.45
BCL2 P10415 6/20 0.43
BECN1 Q14457 6/20 0.43
MIF P14174 4/20 0.43
PSMB8 P28062 1/20 0.43
KMT2A Q03164 4/20 0.42
MEN1 O00255 3/20 0.42
MAPK10 P53779 2/20 0.42
HDAC3 O15379 2/20 0.41
HDAC1 Q13547 2/20 0.41
HDAC2 Q92769 1/20 0.41
HDAC8 Q9BY41 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
CYP1A2 P05177 1/20 0.41
MAPT P10636 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
HDAC10 Q969S8 1/20 0.41
HDAC6 Q9UBN7 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7371723 0.87 CYP17A1 (0.46) CYP17A1BCL2BECN1MIFPSMB8
SCHEMBL7371172 0.77 MIF (0.62) CYP17A1MIFHDAC6
SCHEMBL31341226 0.72 KMT2A (0.54) MIFKMT2ACYP1A2CYP2C9CYP2C19
SCHEMBL1259192 0.72 S1PR1 (0.51) CYP17A1BCL2BECN1PSMB8KMT2A
SCHEMBL20865536 0.70 CYP17A1 (0.68) CYP17A1PSMB8HDAC3HDAC1HDAC2
SCHEMBL13055402 0.68 CYP17A1 (0.59) CYP17A1PSMB8SMN1; SMN2
SCHEMBL6607121 0.66 CYP17A1 (0.58) CYP17A1PSMB8HDAC3HDAC1HDAC2
SCHEMBL4759920 0.66 CYP17A1 (0.79) CYP17A1BCL2BECN1PSMB8HDAC3
SCHEMBL26328838 0.65 CYP17A1 (0.55) CYP17A1BCL2BECN1PSMB8HDAC3
SCHEMBL18570243 0.65 CYP17A1 (0.61) CYP17A1BCL2BECN1PSMB8KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5849736-A Isoxazoline and isoxazole fibrinogen receptor antagonists THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) 1998-12-15 US disclosed